1. Home
  2. EARN vs CVRX Comparison

EARN vs CVRX Comparison

Compare EARN & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$5.62

Market Cap

200.3M

Sector

Real Estate

ML Signal

HOLD

Logo CVRx Inc.

CVRX

CVRx Inc.

HOLD

Current Price

$5.19

Market Cap

201.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
CVRX
Founded
2012
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
200.3M
201.0M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
EARN
CVRX
Price
$5.62
$5.19
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$5.88
$13.17
AVG Volume (30 Days)
338.6K
257.5K
Earning Date
02-20-2026
02-03-2026
Dividend Yield
17.02%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,893,000.00
$55,969,000.00
Revenue This Year
$8.43
$11.91
Revenue Next Year
$17.28
$15.28
P/E Ratio
N/A
N/A
Revenue Growth
43.30
18.44
52 Week Low
$4.33
$4.30
52 Week High
$6.82
$18.55

Technical Indicators

Market Signals
Indicator
EARN
CVRX
Relative Strength Index (RSI) 67.38 23.14
Support Level $5.23 $5.34
Resistance Level $5.57 $6.09
Average True Range (ATR) 0.10 0.65
MACD 0.02 -0.21
Stochastic Oscillator 100.00 1.43

Price Performance

Historical Comparison
EARN
CVRX

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: